DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 140 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $325,883 | +1060.4% | 23,649 | +1291.1% | 0.01% | +500.0% |
| Q1 2024 | $28,084 | +1.0% | 1,700 | -10.8% | 0.00% | – |
| Q4 2023 | $27,813 | +33.9% | 1,905 | +12.5% | 0.00% | -100.0% |
| Q3 2023 | $20,773 | -45.1% | 1,693 | -46.6% | 0.00% | 0.0% |
| Q2 2023 | $37,861 | +41505.5% | 3,171 | -53.3% | 0.00% | -66.7% |
| Q1 2023 | $91 | +71.7% | 6,786 | +178.6% | 0.00% | +50.0% |
| Q4 2022 | $53 | -99.9% | 2,436 | +11.4% | 0.00% | +100.0% |
| Q3 2022 | $44,000 | -34.3% | 2,186 | -41.7% | 0.00% | -50.0% |
| Q2 2022 | $67,000 | +272.2% | 3,750 | +107.2% | 0.00% | – |
| Q1 2022 | $18,000 | +5.9% | 1,810 | +72.9% | 0.00% | – |
| Q4 2021 | $17,000 | +41.7% | 1,047 | +96.1% | 0.00% | – |
| Q3 2021 | $12,000 | – | 534 | +5240.0% | 0.00% | – |
| Q2 2021 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |